glp-1 class drugs Agonists: A Comprehensive Overview glp 1 agonists drug class
Description
A recent meta-analysis by Sattar et al
Concerns include reports of adverse events, some requiring hospitalization, that may be related to dosing errors or doses beyond what is in the FDA-approved drug label, which means using more product in a single dose, taking doses more frequently or increasing the amount more quickly (titration schedule)
Additionally, some drug manufacturers offer patient assistance programs or coupons to help offset the cost of their medications, which can be explored as an alternative
De SA, Salem V, Long CJ, et al
Glucagon-like peptide-1 agonists (GLP-1RA, GLP-1DAs, incretin mimetics, or GLP-1 analogs) represent a category of therapeutics used in the treatment of type 2 diabetes mellitus (T2DM) and obesity
Its a metabolic bomb
